cleveland.com: Jonathan Stamler, professor at the School of Medicine, discussed his team’s discovery that could potentially provide a new target to treat diabetes: an enzyme that regulates the effects of nitric oxide on insulin receptors.
Medicine's Jonathan Stamler discusses the role of nitric oxide in diabetes
MEDIA |
January 26, 2024
STORY BY: EDITORIAL STAFF
STORY BY: EDITORIAL STAFF